Frontiers in Psychiatry | Psychopharmacology

Review

Published on 10 Jan 2024

A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

in Psychopharmacology

Colin J. McArdle
Alana A. Arnone
Chelcie F. Heaney
Kimberly F. Raab-Graham

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1296527

3,707 views
9 citations

Original Research

Published on 08 Jan 2024

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

in Psychopharmacology

Nathan T. Jones
Laura Wagner
Molly C. Pellitteri Hahn
Cameron O. Scarlett
Cody J. Wenthur

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1303365

6,077 views
4 citations

Original Research

Published on 08 Jan 2024

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

in Psychopharmacology

Helena D. Aicher
Michael J. Mueller
Dario A. Dornbierer
Dila Suay
Claudius Elsner
Ilhui Wicki
Daniel Meling
Luzia Caflisch
Alexandra Hempe
Camilla Steinhart

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1302559

7,756 views
11 citations

Perspective

Published on 05 Jan 2024

Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

in Psychopharmacology

Tobias Banaschewski
Alexander Häge
Sarah Hohmann
Konstantin Mechler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1289157

11,114 views
6 citations

Case Report

Published on 27 Dec 2023

Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process

in Psychopharmacology

Matej Stuhec
Borjanka Batinic

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1263464

2,375 views
7 citations

Original Research

Published on 12 Dec 2023

Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data

in Psychopharmacology

Michael Dörks
Christian J. Bachmann
Maike Below
Falk Hoffmann
Lena M. Paschke
Oliver Scholle

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1264047

5,400 views
3 citations

Mini Review

Published on 08 Dec 2023

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management

in Psychopharmacology

Alina Wilkowska
Wiesław Jerzy Cubała

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1322752

5,771 views
5 citations

Editorial

Published on 06 Dec 2023

Editorial: Safety and side effects of psychotropic medications, volume II

in Psychopharmacology

Renato de Filippis
Mireia Solerdelcoll
Mohammadreza Shalbafan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1326118

1,203 views

Review

Published on 05 Dec 2023

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review

in Psychopharmacology

Rafał Marecki
Joanna Kałuska
Agata Kolanek
Dominika Hakało
Napoleon Waszkiewicz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1298359

13,445 views
11 citations

Case Report

Published on 28 Nov 2023

Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy

in Psychopharmacology

Alexander Kaltenboeck
Elisa Foerster
Sabrina Strafner
Ulrike Demal
Nilufar Mossaheb
Fabian Friedrich

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1291077

3,578 views
1 citation

Mini Review

Published on 28 Nov 2023

Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies

in Psychopharmacology

György Purebl
Katharina Schnitzspahn
Éva Zsák

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1268194

5,661 views
8 citations

Original Research

Published on 27 Nov 2023

Anti-depressant medication use is a risk factor for incident knee surgery and opioid use in patients with knee osteoarthritis

in Psychopharmacology

Yongqiang Zheng
Jinshan Zhang
Zefeng Wang
Xiaofeng Liu
Yongquan Xu
Yangzhen Fang
Zhenyu Lin
Liang Lin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1243124

1,158 views

Case Report

Published on 23 Nov 2023

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

in Psychopharmacology

Anya Ragnhildstveit
Ryan Khan
Paul Seli
Lisa Claire Bass
River Jude August
Miriam Kaiyo
Nathaniel Barr
Laura Kate Jackson
Michael Santo Gaffrey
Joseph Peter Barsuglia

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1271152

17,270 views
4 citations

Review

Published on 23 Nov 2023

Overcoming the myths of esketamine administration: different and not difficult

in Psychopharmacology

Florian Buchmayer
Siegfried Kasper

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1279657

6,600 views
4 citations

Perspective

Published on 21 Nov 2023

Biological studies of clavine alkaloids targeting CNS receptors

in Psychopharmacology

Nikhil R. Tasker
Ethan J. Pazur
Peter Wipf

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1286941

2,369 views
3 citations

Editorial

Published on 17 Nov 2023

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms

in Psychopharmacology

Roberto Esposito
HuaLin Cai
Wenbin Guo
Haibin Dai
Pei Jiang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1269307

1,261 views

Navigation group

Articles

A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process

Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management

Editorial: Safety and side effects of psychotropic medications, volume II

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review

Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy

Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies

Anti-depressant medication use is a risk factor for incident knee surgery and opioid use in patients with knee osteoarthritis

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Overcoming the myths of esketamine administration: different and not difficult

Biological studies of clavine alkaloids targeting CNS receptors

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms